[{"address1": "Building A", "address2": "Level 1 7-11 Talavera Road", "city": "Macquarie Park", "state": "NSW", "zip": "2113", "country": "Australia", "phone": "61 2 8063 1600", "fax": "61 2 9418 3743", "website": "https://www.nanosonics.com.au", "industry": "Medical Instruments & Supplies", "sector": "Healthcare", "longBusinessSummary": "Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.", "fullTimeEmployees": 466, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael C. Kavanagh BSc, M.B.A.", "title": "CEO, President, MD & Executive Director", "fiscalYear": 2024, "totalPay": 795139, "exercisedValue": 436708, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sunny  Pillai", "title": "Chief Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jon  Burdach Ph.D.", "title": "Chief Medical Affairs & Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Carbines B.Com., L.L.B.", "title": "General Counsel & Company Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Lipscombe B.E., B.Sc., M.B.A.", "title": "Chief Marketing Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jodi  Sampson M.A.I.C.D., M.B.A.", "title": "Chief People & Culture Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ken  Shaw B.Sc.", "title": "Regional President of United States, Canada & Latin America", "fiscalYear": 2024, "totalPay": 400990, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ronan  Wright B.E., B.Sc.", "title": "Regional President of Europe, Middle East & Africa (EMEA)", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Katsumi  Maruyama L.L.B.", "age": 65, "title": "President of Nanosonics Japan K.K.", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ines  Klatt", "title": "Head of Business Development & Sales Lead D-A-CH", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 4, "compensationRisk": 4, "shareHolderRightsRisk": 1, "overallRisk": 3, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 4, "previousClose": 2.0, "open": 2.0, "dayLow": 2.0, "dayHigh": 2.0, "regularMarketPreviousClose": 2.0, "regularMarketOpen": 2.0, "regularMarketDayLow": 2.0, "regularMarketDayHigh": 2.0, "beta": 1.553, "trailingPE": 68.333336, "volume": 1432, "regularMarketVolume": 1432, "averageVolume": 83, "averageVolume10days": 80, "averageDailyVolume10Day": 80, "bid": 1.9, "ask": 1.96, "bidSize": 40000, "askSize": 40000, "marketCap": 699392320, "fiftyTwoWeekLow": 1.724, "fiftyTwoWeekHigh": 2.95, "priceToSalesTrailing12Months": 4.113782, "fiftyDayAverage": 1.8876, "twoHundredDayAverage": 2.09256, "currency": "USD", "enterpriseValue": 500896576, "profitMargins": 0.0763, "floatShares": 257133064, "sharesOutstanding": 302998016, "heldPercentInsiders": 0.15716, "heldPercentInstitutions": 0.5453, "bookValue": 0.601, "priceToBook": 3.4109817, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1719705600, "earningsQuarterlyGrowth": -0.285, "netIncomeToCommon": 12972000, "trailingEps": 0.03, "enterpriseToRevenue": 2.946, "enterpriseToEbitda": 38.248, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "NNCSF", "underlyingSymbol": "NNCSF", "shortName": "NANOSONICS LIMITED", "longName": "Nanosonics Limited", "firstTradeDateEpochUtc": 1344864600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ea8a53b0-cd2a-3ba9-8081-a26e1667d825", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.05, "recommendationKey": "none", "totalCash": 129552000, "totalCashPerShare": 0.428, "ebitda": 13096000, "totalDebt": 9303000, "quickRatio": 5.281, "currentRatio": 6.158, "totalRevenue": 170012000, "debtToEquity": 5.106, "revenuePerShare": 0.562, "returnOnAssets": 0.023440002, "returnOnEquity": 0.07497, "freeCashflow": 13543375, "operatingCashflow": 22782000, "earningsGrowth": -0.295, "revenueGrowth": 0.07, "grossMargins": 0.77899003, "ebitdaMargins": 0.07703, "operatingMargins": 0.056929998, "financialCurrency": "AUD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]